MariMed Inc.
MRMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $157,964 | $148,598 | $134,010 | $121,464 |
| % Growth | 6.3% | 10.9% | 10.3% | – |
| Cost of Goods Sold | $95,096 | $82,679 | $70,053 | $55,201 |
| Gross Profit | $62,868 | $65,919 | $63,957 | $66,263 |
| % Margin | 39.8% | 44.4% | 47.7% | 54.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $52,677 | $44,744 | $35,139 | $35,912 |
| SG&A Expenses | $59,341 | $50,839 | $38,875 | $37,537 |
| Sales & Mktg Exp. | $6,664 | $5,977 | $3,736 | $1,625 |
| Other Operating Expenses | $615 | $0 | -$127 | $307 |
| Operating Expenses | $59,956 | $51,534 | $38,875 | $37,537 |
| Operating Income | $2,912 | $15,080 | $20,369 | $26,863 |
| % Margin | 1.8% | 10.1% | 15.2% | 22.1% |
| Other Income/Exp. Net | -$6,880 | -$21,676 | -$861 | -$3,048 |
| Pre-Tax Income | -$3,968 | -$6,596 | $19,508 | $23,816 |
| Tax Expense | $8,159 | $9,411 | $5,894 | $16,192 |
| Net Income | -$12,164 | -$16,031 | $13,468 | $7,225 |
| % Margin | -7.7% | -10.8% | 10% | 5.9% |
| EPS | -0.032 | -0.044 | 0.04 | 0.022 |
| % Growth | 27.2% | -210.5% | 80.5% | – |
| EPS Diluted | -0.032 | -0.044 | 0.035 | 0.019 |
| Weighted Avg Shares Out | 379,153 | 363,403 | 337,697 | 326,467 |
| Weighted Avg Shares Out Dil | 379,153 | 363,403 | 380,289 | 372,397 |
| Supplemental Information | – | – | – | – |
| Interest Income | $114 | $270 | $959 | $108 |
| Interest Expense | $6,944 | $9,185 | $1,693 | $2,356 |
| Depreciation & Amortization | $10,858 | $8,574 | $4,714 | $2,788 |
| EBITDA | $13,834 | $11,163 | $25,915 | $28,960 |
| % Margin | 8.8% | 7.5% | 19.3% | 23.8% |